These data suggest that the H2O2-REST-Cav2.2 channel signaling axis could be a potential therapeutic target to normalize cardiac vagal dysfunction and reduce the mortality in T2DM. The gene discussed is CACNA1B; the disease is type 2 diabetes mellitus.